Goldman Sachs Downgrades Cohen & Steers (CNS) to Sell, Cites Risk to Flows

September 12, 2012 7:13 AM EDT Send to a Friend
Get Alerts CNS Hot Sheet
Price: $41.72 --0%

Rating Summary:
    2 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 20 | New: 16
Trade CNS Now!
Join SI Premium – FREE
Goldman Sachs downgraded Cohen & Steers (NYSE: CNS) from Neutral to Sell with a price target of $26.50 (from $31.00), suggesting 21% downside.

The firm cited: "(1) Significant deterioration in the firm's asset-weighted three-year performance record plus increasing competition from lower fee passive competitors
like Vanguard and iShares are likely to drive market share erosion in the US REIT space; (2) CNS’s Japanese sub-advised business (most of the $19 bn total sub-advised AUM), should see further flow deterioration after dividend cuts in several of those funds in 3Q12; and (3) valuation does not reflect softening fundamentals and the stock trades at a premium multiple relative."

Goldman raised 2012 EPS estimate to $1.58 from $1.56 on better market performance in 3Q12TD but lower 2013/2014 EPS to $1.67/$1.88 from $1.72/$2.01 on more conservative flow outlook.

For an analyst ratings summary and ratings history on Cohen & Steers click here. For more ratings news on Cohen & Steers click here.

Shares of Cohen & Steers closed at $33.71 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst EPS Change, Analyst PT Change, Downgrades

Related Entities

Goldman Sachs, Dividend, Cohen and Steers, Vanguard

Add Your Comment